Amicus Therapeutics Inc 's (FOLD) Outlook - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Amicus Therapeutics inc   (NASDAQ: FOLD)
 



  Amicus Therapeutics inc Outlook

On January 12 2025 the Amicus Therapeutics inc provided following guidance

nnAmicus Therapeutics Inc. Provides Preliminary 2024 Revenue Figures and Strategic Outlook for 2025nn

Amicus Therapeutics Inc. has announced its preliminary revenue figures for 2024, revealing a total revenue of $528 million. This impressive figure signifies a robust growth rate of 32% compared to the previous year, highlighting the company’s strong performance and successful market strategies.

As we look ahead to 2025, the company has outlined its strategic goals and objectives, emphasizing a commitment to sustaining this growth trajectory. The financial guidance offered by Amicus underscores their confidence in continued expansion and the potential for increased market presence.

In summary, Amicus Therapeutics is on a promising path, with a significant revenue milestone achieved in 2024 and an ambitious outlook set for 2025.,





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.